Review the characteristics of breakthrough pain and its negative impact on patients with cancer, and reinforce the need to treat this pain as a separate entity from baseline pain.
Preliminary results show that the use of nanotechnology allowed for the detection of 6 biomarkers associated with prostate cancer, and might enhance the ability to diagnose the disease in its early state. Medscape Medical News
